Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica

被引:42
|
作者
De Miguel, Eugenio [1 ,9 ]
Macchioni, Pierluigi [2 ]
Conticini, Edoardo [3 ]
Campochiaro, Corrado [4 ]
Karalilova, Rositsa [5 ]
Monti, Sara [6 ]
Ponte, Cristina [7 ]
Klinowski, Giulia [2 ]
Monjo-Henry, Irene [1 ]
Falsetti, Paolo [3 ]
Batalov, Zguro [5 ]
Tomelleri, Alessandro [4 ]
Hocevar, Alojzija [8 ]
机构
[1] Hosp Univ La Paz, Rheumatol Dept, Madrid, Spain
[2] IRCCS S Maria Nuova, Dept Rheumatol, Reggio Emilia, Italy
[3] Univ Siena, Dept Med Surg & Neurosci, Rheumatol Unit, Siena, Italy
[4] Ist Sci San Raffaele, Rheumatol Dept, Unit Immunol, Allergy & Rare Dis UnIRAR, Milan, Italy
[5] Univ Hosp Kaspela, Med Univ Plovdiv, Rheumatol Dept, Plovdiv, Bulgaria
[6] Univ Pavia, IRCCS Policlin S Matteo Fdn, Dept Rheumatol, Pavia, Italy
[7] Ctr Hosp Univ Lisboa Norte EPE, Hosp Santa Maria, Rheumatol Dept, Lisbon, Portugal
[8] Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia
[9] Hosp Univ La Paz, Rheumatol Dept, P Castellana 261, Madrid 28046, Spain
关键词
PMR; GCA; vasculitis; epidemiology; ultrasonography; COLOR DOPPLER SONOGRAPHY; TEMPORAL ARTERITIS; ULTRASOUND; DIAGNOSIS; ATHEROSCLEROSIS; INVOLVEMENT;
D O I
10.1093/rheumatology/kead189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The main objective of this study was to analyse the prevalence and characteristics of subclinical GCA in patients with PMR. Methods This was a cross-sectional multicentre international study of consecutive patients with newly diagnosed PMR without symptoms or signs suggestive of GCA. All patients underwent US of the temporal superficial, common carotid, subclavian and axillary arteries. Patients with halo signs in at least one examined artery were considered to have subclinical GCA. The clinical, demographic and laboratory characteristics of the PMR group without subclinical vasculitis were compared with subclinical GCA, and the pattern of vessel involvement was compared with that of a classical single-centre GCA cohort. Results We included 346 PMR patients, 267 (77.2%) without subclinical GCA and 79 (22.8%) with subclinical GCA. The PMR patients with subclinical GCA were significantly older, had a longer duration of morning stiffness and more frequently reported hip pain than PMR without subclinical GCA. PMR with subclinical GCA showed a predominant extracranial large vessel pattern of vasculitic involvement compared with classical GCA, where the cranial phenotype predominated. The patients with PMR in the classical GCA group showed a pattern of vessel involvement similar to classical GCA without PMR but different from PMR with subclinical involvement. Conclusion More than a fifth of the pure PMR patients had US findings consistent with subclinical GCA. This specific subset of patients showed a predilection for extracranial artery involvement. The optimal screening strategy to assess the presence of vasculitis in PMR remains to be determined.
引用
收藏
页码:158 / 164
页数:7
相关论文
共 50 条
  • [21] Review of phase 2/3 trials in polymyalgia rheumatica and giant cell arteritis
    Nageswaran, Pratheeshaa
    Ahmed, Saad
    Tahir, Hasan
    EXPERT OPINION ON EMERGING DRUGS, 2024, 29 (01) : 5 - 17
  • [22] COGNITIVE FUNCTION IN POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS
    Harkins, P.
    Cowley, S.
    Kane, D.
    Conway, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1580 - 1581
  • [23] Polymyalgia Rheumatica and Giant Cell Arteritis A Systematic Review
    Buttgereit, Frank
    Dejaco, Christian
    Matteson, Eric L.
    Dasgupta, Bhaskar
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (22): : 2442 - 2458
  • [24] Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis
    Matteson, Eric L.
    Buttgereit, Frank
    Dejaco, Christian
    Dasgupta, Bhaskar
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (01) : 75 - +
  • [25] Giant Cell Arteritis and Polymyalgia Rheumatica - An Interdisciplinary Challenge
    Decard, B. F.
    Bley, T. A.
    Peter, H. H.
    Gold, R.
    AKTUELLE NEUROLOGIE, 2010, 37 (02) : 92 - 103
  • [26] Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis
    Muratore, F.
    Pipitone, N.
    Hunder, G. G.
    Salvarani, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) : S86 - S92
  • [27] Additional Costs of Polymyalgia Rheumatica With Giant Cell Arteritis
    Mounie, Michael
    Pugnet, Gregory
    Savy, Nicolas
    Lapeyre-Mestre, Maryse
    Molinier, Laurent
    Costa, Nadege
    ARTHRITIS CARE & RESEARCH, 2019, 71 (08) : 1127 - 1131
  • [28] Differential Diagnosis of Polymyalgia Rheumatica and Giant Cell Arteritis
    Keysser, G.
    AKTUELLE RHEUMATOLOGIE, 2014, 39 (04) : 227 - 231
  • [29] Clinical Signs and Laboratory Findings of Polymyalgia Rheumatica and Giant Cell Arteritis
    Keysser, G.
    AKTUELLE RHEUMATOLOGIE, 2014, 39 (04) : 223 - 226
  • [30] WHAT IS THE OUTCOME OF PATIENTS WITH OR WITHOUT SUBCLINICAL GIANT CELL ARTERITIS IN POLYMYALGIA RHEUMATICA? PRELIMINARY DATA OF AN OBSERVATION STUDY
    De Miguel, E.
    Karalilova, R.
    Macchioni, P.
    Campochiaro, C.
    Ponte, C.
    Conticini, E.
    Cowley, S.
    Monti, S.
    Monjo, I.
    Batalov, Z.
    Klinowski, G.
    Falsetti, P.
    Kane, D.
    Tomelleri, A.
    Hocevar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 642 - 642